Vol 2, No 1 (March 10, 2013): Chinese Clinical Oncology

Editorials

Can EGFR mutation status evolve with chemotherapy?

Eric S. Kim, David J. Stewart, Alok A. Khorana

PDF Pages: 1 Full Text (10261) Open Access

EGFR mutation in lung cancer: tumor heterogeneity and the impact of chemotherapy

Jair Bar, Damien Urban, Roni Borshtein, Hovav Nechushtan, Amir Onn

PDF Pages: 2 Full Text (11734) Open Access

Drifting EGFR mutation

Rintaro Noro, Tesshi Yamada

PDF Pages: 3 Full Text (6246) Open Access

Original Article

Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments

Laura E. Johnson, Jordan T. Becker, Jason A. Dubovsky, Brian M. Olson, Douglas G. McNeel

PDF Pages: 4 Full Text (11178) Open Access

Review Articles

Molecular therapy for gastric cancer

Yasuhide Yamada

PDF Pages: 5 Full Text (18413) Open Access

Current status and future direction of chemotherapy for pancreatic cancer

Junji Furuse, Fumio Nagashima

PDF Pages: 6 Full Text (16696) Open Access

The B7-H1/PD-1 pathway in cancers associated with infections and inflammation: opportunities for therapeutic intervention

Patrick A. Ott, F. Stephen Hodi

PDF Pages: 7 Full Text (18241) Open Access

Colorectal cancer screening: are stool and blood based tests good enough?

Chung-Wah Wu, Joseph Jao-Yiu Sung

PDF Pages: 8 Full Text (39262) Open Access

The future of clinical research in oncology: where are we heading to?

Denis Lacombe, Yan Liu

PDF Pages: 9 Full Text (18827) Open Access

Perspective

Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant

Valerie Nelson, Alfred Rademaker, Virginia Kaklamani

PDF Pages: 10 Full Text (8725) Open Access